ImmuCell Corp (NASDAQ:ICCC)

7.00
Delayed Data
As of Mar 02
 +0.35 / +5.26%
Today’s Change
3.30
Today|||52-Week Range
7.22
+44.03%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.65
Today’s open6.65
Day’s range-- - --
Volume2,036
Average volume (3 months)4,977
Market cap$20.1M
Dividend yield--
Data as of 03/02/2015

Growth & Valuation

Earnings growth (last year)-250.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+26.47%
P/E ratioNM
Price/Sales1.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGBPRegen BioPharma Inc+0.04+11.43%
CBMXCombiMatrix Corp-0.06-2.91%
GENEGenetic Technologies...-0.10-1.72%
RXIIRxi Pharmaceuticals ...-0.02-1.72%
Data as of 03/02/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$7.6M
Annual profit (last year)-$167.0K
Net profit margin-2.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, CFO, Secretary &
Treasurer
Michael F. Brigham
Director, Chief Scientific Officer &
VP
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account